Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of Association Between the Outcomes of Aortic Valve Implantation and Edge-to-Edge Repair at US Transcatheter Valve Programs.

The American journal of cardiology·2023
Same author

Hemodynamic Profiling of Patients Undergoing Transcatheter Mitral Edge-to-Edge Repair.

JACC. Cardiovascular interventions·2023
Same author

Nonthrombogenic Roles of the Left Atrial Appendage: JACC Review Topic of the Week.

Journal of the American College of Cardiology·2023
Same author

Risks of Right Heart Catheterization and Right Ventricular Biopsy: A 12-year, Single-Center Experience.

Mayo Clinic proceedings·2023
Same author

The impact of baseline transmitral diastolic mean gradient on left atrial pressure reduction in patients undergoing transcatheter mitral valve edge-to-edge repair.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2023
Same author

Impact of Persistent Iatrogenic Atrial Septal Defect following MitraClip.

Journal of cardiovascular development and disease·2023

Related Experiment Video

Updated: Jun 26, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Current trends in coronary revascularization.

Shannon M Dunlay1, Charanjit S Rihal, Thoralf M Sundt

  • 1Véronique L. Roger, MD, MPH Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. roger.veronique@mayo.edu.

Current Treatment Options in Cardiovascular Medicine
|January 15, 2009
PubMed
Summary
This summary is machine-generated.

Percutaneous coronary intervention (PCI) use has risen, while coronary artery bypass grafting (CABG) has declined, with historical disparities narrowing. The ongoing debate on PCI versus CABG appropriateness continues amid evolving factors.

More Related Videos

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Related Experiment Videos

Last Updated: Jun 26, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Coronary revascularization options expanded with bare-metal and drug-eluting stents.
  • Percutaneous coronary intervention (PCI) use increased, while coronary artery bypass grafting (CABG) decreased.

Purpose of the Study:

  • To analyze trends in PCI versus CABG utilization.
  • To examine factors influencing the choice between PCI and CABG.
  • To assess the narrowing of historical disparities in revascularization procedures.

Main Methods:

  • Analysis of trends in coronary revascularization procedures.
  • Review of factors influencing procedural choices and utilization.
  • Examination of demographic trends in patients undergoing revascularization.

Main Results:

  • PCI rates have increased, whereas CABG rates have decreased.
  • Historical disparities in revascularization use among women, elderly, and nonwhite patients appear to be narrowing.
  • The optimal choice between PCI and CABG remains debated, influenced by patient anatomy, function, and comorbidities.

Conclusions:

  • The trend of increased PCI use over CABG may continue, but is subject to multiple influencing factors.
  • Ongoing evaluation of clinical evidence, technology, guidelines, and reimbursement is necessary.
  • The debate on PCI versus CABG appropriateness persists in clinical practice.